- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01202201
A Retrospective Survey of the Burden of Rotavirus Gastroenteritis (RV GE) and Nosocomial RV GE in Japan
June 6, 2017 updated by: GlaxoSmithKline
A Retrospective Survey of the Burden of Rotavirus Gastroenteritis (RV GE) and Nosocomial RV GE in Children <6 Years of Age in Japan
The purpose of this study is to evaluate the epidemiology and baseline disease burden of rotavirus gastroenteritis in children < 6 years of age, in Japan.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This is a retrospective database study wherein data on children who have been diagnosed with acute gastroenteritis or rotavirus gastroenteritis will be collected from the electronic admission database or any other applicable database of the participating hospitals.
Study Type
Observational
Enrollment (Actual)
13767
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 6 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Children <6 years of age hospitalized with acute gastroenteritis or rotavirus gastroenteritis in any of the participating hospitals
Description
Inclusion Criteria:
- A male or female child aged <6 years at the time of admission in hospital. A child will become ineligible on the day of her/his sixth birthday.
- A subject who is hospitalized with any acute gastroenteritis or rotavirus gastroenteritis during the survey period.
Exclusion Criteria:
- Participants of any kind of rotavirus vaccine clinical trial.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Study Cohort
Subjects hospitalized with acute gastroenteritis or rotavirus gastroenteritis
|
Review and collect data from database (electronic admission database or any other applicable database of the hospital)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Occurrence of acute gastroenteritis among all hospitalized children aged <6 years
Time Frame: At least 24 months (from 01 January 2008 to 31 December 2009)
|
At least 24 months (from 01 January 2008 to 31 December 2009)
|
|
Occurrence of rotavirus gastroenteritis among all hospitalized children aged <6 years
Time Frame: At least 24 months (from 01 January 2008 to 31 December 2009)
|
At least 24 months (from 01 January 2008 to 31 December 2009)
|
|
Occurrence of rotavirus gastroenteritis among all acute gastroenteritis hospitalizations in children aged <6 years
Time Frame: At least 24 months (from 01 January 2008 to 31 December 2009)
|
At least 24 months (from 01 January 2008 to 31 December 2009)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Occurrence of nosocomial rotavirus gastroenteritis among all hospitalized children aged <6 years
Time Frame: At least 24 months (from 01 January 2008 to 31 December 2009)
|
At least 24 months (from 01 January 2008 to 31 December 2009)
|
|
Occurrence of nosocomial rotavirus gastroenteritis among all hospitalizations with rotavirus gastroenteritis in children aged <6 years
Time Frame: At least 24 months (from 01 January 2008 to 31 December 2009)
|
At least 24 months (from 01 January 2008 to 31 December 2009)
|
|
Prolongation of hospitalization of patients with nosocomial rotavirus gastroenteritis
Time Frame: At least 24 months (from 01 January 2008 to 31 December 2009)
|
At least 24 months (from 01 January 2008 to 31 December 2009)
|
|
Occurrence of rotavirus gastroenteritis hospitalization and nosocomial rotavirus gastroenteritis hospitalization among children <6 years of age, stratified by age
Time Frame: At least 24 months (from 01 January 2008 to 31 December 2009)
|
At least 24 months (from 01 January 2008 to 31 December 2009)
|
|
Seasonal distribution (monthly) of rotavirus gastroenteritis infection
Time Frame: At least 24 months (from 01 January 2008 to 31 December 2009)
|
At least 24 months (from 01 January 2008 to 31 December 2009)
|
|
Age (monthly) specific data of all the outcome measures, for children <12 months of age
Time Frame: At least 24 months (from 01 January 2008 to 31 December 2009)
|
At least 24 months (from 01 January 2008 to 31 December 2009)
|
|
Number of hospitalizations with rotavirus gastroenteritis and other vaccine-preventable infectious diseases such as influenza, mumps and varicella among children <6 years of age
Time Frame: At least 24 months (from 01 January 2008 to 31 December 2009)
|
At least 24 months (from 01 January 2008 to 31 December 2009)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (Actual)
February 1, 2011
Study Completion (Actual)
February 1, 2011
Study Registration Dates
First Submitted
September 14, 2010
First Submitted That Met QC Criteria
September 14, 2010
First Posted (Estimate)
September 15, 2010
Study Record Updates
Last Update Posted (Actual)
June 7, 2017
Last Update Submitted That Met QC Criteria
June 6, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 114131
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rotavirus Gastroenteritis
-
GlaxoSmithKlineCompletedInfections, Rotavirus | Rotavirus Gastroenteritis
-
Romark Laboratories L.C.CompletedRotavirus Infection | Viral Gastroenteritis Due to RotavirusEgypt
-
Sinovac Life Sciences Co., Ltd.CompletedRotavirus GastroenteritisChina
-
University Hospital for Infectious Diseases, CroatiaCompletedRotavirus GastroenteritisCroatia
-
Merck Sharp & Dohme LLCCompleted
-
MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd.ParexelCompletedRotavirus GastroenteritisBangladesh
-
PATHCenters for Disease Control and Prevention; Noguchi Memorial Institute for... and other collaboratorsCompletedRotavirus GastroenteritisGhana
-
GlaxoSmithKlineCompletedRotavirus GastroenteritisGreece
-
Shantha Biotechnics LimitedCompletedRotavirus GastroenteritisIndia
-
Shantha Biotechnics LimitedUnknownRotavirus GastroenteritisIndia
Clinical Trials on Database analysis
-
GlaxoSmithKlineCompletedGastroenteritis | DiarrhoeaBrazil
-
University of British ColumbiaWomen's Health Research Institute of British ColumbiaActive, not recruitingPregnancy Complications | Pregnancy Related | Morbidity;Perinatal
-
SanofiActive, not recruitingPertussis (Whooping Cough)France
-
GEMA LEÓN BRAVOCompleted
-
GlaxoSmithKlineCompletedGastroenteritis | Rotavirus Gastroenteritis
-
Hospices Civils de LyonCompletedHIV | Pre-exposure ProphylaxisFrance
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruiting
-
King Faisal Specialist Hospital & Research CenterUnknownLymphoma, Non-Hodgkin | Hodgkin DiseaseSaudi Arabia
-
King Faisal Specialist Hospital & Research CenterUnknown